Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05730491 · ClinicalTrials.gov registry record · NA
Online Social Learning Program for Parents With Irritable Bowel Syndrome: Raising Resilient Children
A NA study of Irritable Bowel Syndrome and Abdominal Pain, sponsored by Seattle Children's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 460
- Enrollment target
- 1
- Study location
NCT05730491: Recruiting NA study of Irritable Bowel Syndrome and Abdominal Pain, sponsored by Seattle Children's Hospital.
NCT05730491 is a NA study of Irritable Bowel Syndrome and Abdominal Pain that is actively recruiting participants, run by Seattle Children's Hospital. The registered enrollment target is 460 participants, above the 134-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (243% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05730491, a NA study of Irritable Bowel Syndrome and Abdominal Pain, is actively recruiting participants, sponsored by Seattle Children's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 460 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to test efficacy of the REACH program in parents with irritable bowel syndrome (IBS) and their young children. The main question it aims to answer is: -How can parents with IBS help their young kids develop healthy habits? Participants will be asked to complete online surveys and to use a website. Researchers will compare results from parents who use one of two websites chosen by chance, like flipping a coin. One website focuses on child health and safety behaviors. The other website focuses on strategies to promote child wellness behaviors.
Primary Outcome
Assesses self-reported parental encouragement of child illness behavior. The Adult Responses to Child Symptoms (ARCS) has 29-items that load onto 3 subscales (Protectiveness, Monitoring/Encouragement, Minimization). Responses are rated on a 5-point scale ranging from "never" to "always." . Higher average scores indicate that the responses are more frequently used, and thus higher scores are less adaptive ways of responding.
Conditions Studied
Interventions
- BEHAVIORAL Social Learning and Cognitive Behavioral Therapy (SLCBT)
- BEHAVIORAL Attention Education Control
Study Locations (1)
Washington
- Seattle Children's Hospital - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 460 participants |
| Start Date | 2023-10-16 |
| Est. Completion | 2027-04-30 |
| Phase | NA |
What NCT05730491 shows while recruiting
NCT05730491 is an interventional study that assigns participants to a tested intervention. The registered 460 participants enrollment target is mid-sized for trials with a published cap, above the 134-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (243% higher).
The record links to 2 conditions, with Irritable Bowel Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Social Learning and Cognitive Behavioral Therapy (SLCBT) is the first listed.
NCT05730491 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT05730491 about?
NCT05730491 is a clinical study titled "Online Social Learning Program for Parents With Irritable Bowel Syndrome: Raising Resilient Children". The goal of this clinical trial is to test efficacy of the REACH program in parents with irritable bowel syndrome (IBS) and their young children. The main question it aims to answer is: -How can parents with IBS help their young kids develop healthy habits? Participants will be asked to complete o...
What is the current status of trial NCT05730491?
This trial is currently recruiting. It is a NA study. The enrollment target is 460 participants. The study started on 2023-10-16. Estimated completion is 2027-04-30.
What conditions does trial NCT05730491 study?
This clinical trial studies the following conditions: Irritable Bowel Syndrome, Abdominal Pain.
What interventions are being tested in trial NCT05730491?
The interventions under investigation include: Social Learning and Cognitive Behavioral Therapy (SLCBT) (BEHAVIORAL), Attention Education Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT05730491?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05730491 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Irritable Bowel Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05730491's enrollment target sits among peer trials
460 2nd of 47 the highest of 47 other Irritable Bowel Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Irritable Bowel Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program?
RECRUITING · NA
-
GI Alpha-Gal Study
RECRUITING · NA
-
Visible Abdominal Distension
RECRUITING · NA
-
IBS Skin Patch Test Food Allergy Study
RECRUITING · NA
-
Standardized Yoga & Meditation Program for Stress Reduction for Adolescents With Irritable Bowel Syndrome
RECRUITING · NA
-
Well-being in IBS: Strengths and Happiness (WISH) 2.0
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02977780 · 460 participants · Phase 2
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
- NCT03427736 · 460 participants
Anesthetics and Analgesics in Children
- NCT03819933 · 460 participants · NA
Optimizing Family Counseling for Anticipated Extremely Preterm Delivery
- NCT04621279 · 460 participants
Cool Prime Comparative Effectiveness Study for Mild HIE
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI